Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt

Bootcov, 1997, MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily, Proc Natl Acad Sci USA, 94, 11514, 10.1073/pnas.94.21.11514 Xu, 2006, GDF 15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation, Circ Res, 98, 342, 10.1161/01.RES.0000202804.84885.d0 Yatsuga, 2015, Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders, Ann Neurol, 78, 814, 10.1002/ana.24506 Kempf, 2006, The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury, Circ Res, 98, 351, 10.1161/01.RES.0000202805.73038.48 Schlittenhardt, 2004, Involvement of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF 15/MIC-1) in oxLDL induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions, Cell Tissue Res, 318, 325, 10.1007/s00441-004-0986-3 Wollert, 2017, Growth differentiation factor 15 as a biomarker in cardiovascular disease, Clin Chem, 63, 140, 10.1373/clinchem.2016.255174 Zhang, 2016, Growth differentiation factor–15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis, BMC Cardiovasc Disord, 16, 1, 10.1186/s12872-016-0250-2 Tomasevic, 2016, Prognostic utility of biomarker growth differentiation factor-15 in patients with acute decompensated heart failure, Acta Cardiol, 71, 587, 10.1080/AC.71.5.3167503 Norozi, 2011, Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects, Am Heart J, 162, 131, 10.1016/j.ahj.2011.03.036 Baggen, 2017, Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease, Circulation, 135, 264, 10.1161/CIRCULATIONAHA.116.023255 Raedle-Hurst, 2010, Growth differentiation factor 15-an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts, Am Heart J, 160, 1105, 10.1016/j.ahj.2010.08.033 Uemura, 2018, Creatinine-based estimated glomerular filtration rate for children younger than 2 years, Clin Exp Nephrol, 22, 483, 10.1007/s10157-017-1460-3 Läer, 2002, Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters, Am Heart J, 143, 916, 10.1067/mhj.2002.121265 Kempf, 2007, Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure, J Am Coll Cardiol, 50, 1054, 10.1016/j.jacc.2007.04.091 Lok, 2014, Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support, Eur J Heart Fail, 14, 1249, 10.1093/eurjhf/hfs120 Fuernau, 2014, Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial, Eur J Heart Fail, 16, 880, 10.1002/ejhf.117 Benes, 2019, The role of GDF-15 in heart failure patients with chronic kidney disease, Can J Cardiol, 35, 462, 10.1016/j.cjca.2018.12.027 Moore, 2000, The transforming growth factor-β superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women, J Clin Endocrinol Metab, 85, 4781 Li, 2017, Plasma growth differentiation factor-15 is a potential biomarker for pediatric pulmonary arterial hypertension associated with congenital heart disease, Pediatr Cardiol, 38, 1620, 10.1007/s00246-017-1705-7